Suppr超能文献

各种免疫抑制剂对小鼠腹腔巨噬细胞以及这些细胞对大肠杆菌O4:K3:H5的体外吞噬作用和125I标记的HSA-抗体复合物降解的影响。

The effect of various immunosuppressive agents on mouse peritoneal macrophages and on the in vitro phagocytosis of Escherichia coli O4:K3:H5 and degradation of 125I-labelled HSA-antibody complexes by these cells.

作者信息

Gadeberg O V, Rhodes J M, Larsen S O

出版信息

Immunology. 1975 Jan;28(1):59-70.

Abstract

Large doses of hydrocortisone, cyclophosphamide, and methotrexate injected subcutaneously, and whole-body irradiation (500 rads) caused a reduction in the number of peritoneal cells (PE cells) obtained after intraperitoneal injection of the treated mice with proteose-peptone. The same dose of cyclophosphamide and irradiation induced morphological changes in PE macrophages. There were more giant cells in the peritoneal exudates from treated mice as compared to control mice. 'Pharmacological' and larger doses of hydrocortisone, methotrexate and azathioprine or anti-lymphocyte globulin had no effect on the in vitro phagocytic capacity of proteose-peptone-stimulated mouse PE macrophages. This also applied to doses of up to 50 mg/kg of cyclophosphamide. In contrast, whole-body irradiation (500 rad) and 100 mg/kg of cyclophosphamide decreased the phagocytic capacity of mouse macrophages in vitro and reduced the ability of PE cells to degrade 125I-labelled HSA-antibody complexes in vitro. The greatest effect was noted 4-5 days after whole-body irradiation or four to five subcutaneous injections of cyclophosphamide.

摘要

皮下注射大剂量氢化可的松、环磷酰胺和甲氨蝶呤,以及全身照射(500拉德),会导致在给经处理的小鼠腹腔注射蛋白胨后获得的腹腔细胞(PE细胞)数量减少。相同剂量的环磷酰胺和照射会诱导PE巨噬细胞出现形态学变化。与对照小鼠相比,经处理小鼠的腹腔渗出液中有更多的巨细胞。“药理”剂量及更大剂量的氢化可的松、甲氨蝶呤和硫唑嘌呤或抗淋巴细胞球蛋白对蛋白胨刺激的小鼠PE巨噬细胞的体外吞噬能力没有影响。这也适用于高达50毫克/千克的环磷酰胺剂量。相比之下,全身照射(500拉德)和100毫克/千克的环磷酰胺会降低小鼠巨噬细胞的体外吞噬能力,并降低PE细胞在体外降解125I标记的HSA-抗体复合物的能力。在全身照射后4至5天或皮下注射环磷酰胺4至5次后观察到最大效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66a9/1445766/57f9cdb3e7d0/immunology00312-0074-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验